Healthcare & Medical Investment Corporation (TYO:3455)
Japan · Delayed Price · Currency is JPY 91,500
+100 (0.11%)
At close: Oct 9, 2026
TYO:3455 Income Statement
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Rental Revenue | 5,287 | 5,176 | 5,036 | 4,877 | 4,799 | 4,153 |
Gain (Loss) on Sale of Assets (Rev) | - | - | - | - | 204.65 | - |
Gain (Loss) on Sale of Investments (Rev) | 6.8 | 6.21 | 1.53 | - | - | - |
Other Revenue | 0 | 0 | - | 0 | 0 | - |
| 5,293 | 5,182 | 5,037 | 4,877 | 5,003 | 4,153 | |
Revenue Growth (YoY | 4.41% | 2.88% | 3.29% | -2.53% | 20.48% | 1.76% |
Property Expenses | 2,445 | 2,374 | 2,288 | 2,193 | 2,106 | 1,789 |
Selling, General & Administrative | 30.29 | 49.29 | 48.19 | 44.67 | 57.6 | 56 |
Other Operating Expenses | 134.64 | 130.93 | 128.72 | 117.14 | 120.32 | 156 |
Total Operating Expenses | 2,610 | 2,554 | 2,465 | 2,354 | 2,284 | 2,001 |
Operating Income | 2,683 | 2,628 | 2,572 | 2,523 | 2,719 | 2,152 |
Interest Expense | -486.68 | -432.98 | -353.75 | -277.71 | -213.07 | -300 |
Interest & Investment Income | 4.8 | 3.16 | 0.29 | 0.15 | 0.09 | - |
Other Non-Operating Income | -125.8 | -122 | -139.31 | -128.13 | -128.15 | -6 |
EBT Excluding Unusual Items | 2,075 | 2,076 | 2,079 | 2,117 | 2,378 | 1,846 |
Total Insurance Settlements | - | 0.28 | 1.77 | 2.34 | 1.82 | - |
Other Unusual Items | - | - | - | - | - | -12 |
Pretax Income | 2,075 | 2,076 | 2,081 | 2,119 | 2,380 | 1,834 |
Income Tax Expense | 1.75 | 1.78 | 1.81 | 1.76 | 1.63 | - |
Net Income | 2,074 | 2,075 | 2,079 | 2,117 | 2,379 | 1,834 |
Net Income to Common | 2,074 | 2,075 | 2,079 | 2,117 | 2,379 | 1,834 |
Net Income Growth | 1.57% | -0.23% | -1.79% | -10.98% | 29.69% | 0.38% |
Basic Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 |
Diluted Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Change | 0.02% | - | - | 0.05% | 15.54% | - |
EPS (Basic) | 5767.04 | 5771.07 | 5784.27 | 5889.94 | 6619.45 | 5897.09 |
EPS (Diluted) | 5767.04 | 5771.07 | 5784.27 | 5889.94 | 6619.45 | 5897.09 |
EPS Growth | 1.55% | -0.23% | -1.79% | -11.02% | 12.25% | 0.38% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Dividend Per Share | 6460.000 | 6450.000 | 6444.000 | 6517.000 | 6924.000 | - |
Dividend Growth | 102.95% | 0.09% | -1.12% | -5.88% | - | - |
Operating Margin | 50.69% | 50.71% | 51.06% | 51.72% | 54.35% | 51.82% |
Profit Margin | 39.17% | 40.04% | 41.28% | 43.42% | 47.54% | 44.16% |
EBITDA | 3,928 | 3,850 | 3,761 | 3,649 | 3,835 | 3,120 |
EBITDA Margin | 74.20% | 74.30% | 74.66% | 74.83% | 76.65% | 75.13% |
D&A For Ebitda | 1,245 | 1,222 | 1,188 | 1,127 | 1,116 | 968 |
EBIT | 2,683 | 2,628 | 2,572 | 2,523 | 2,719 | 2,152 |
EBIT Margin | 50.69% | 50.71% | 51.06% | 51.72% | 54.35% | 51.82% |
Funds From Operations (FFO) | 3,290 | 3,290 | 3,266 | 3,243 | 3,289 | - |
Adjusted Funds From Operations (AFFO) | - | 3,290 | 3,266 | 3,243 | 3,289 | - |
FFO Payout Ratio | 70.46% | 69.36% | 71.49% | 75.77% | 67.42% | - |
Effective Tax Rate | 0.08% | 0.09% | 0.09% | 0.08% | 0.07% | - |
Revenue as Reported | 5,293 | 5,182 | 5,037 | 4,877 | 5,003 | - |